There is clinical potential for miRNA as therapeutics in metabolic disease

miRNAs have been shown to be involved in a wide range of biological processes with highly tissue specific expression and distinct temporal expression patterns.

There is a urgent need for the development of novel and effective approaches for treatment of metabolic diseases such as diabetic nephropathy and osteoporosis. Targeting inhibition of miRNAs may provide new therapeutic approaches for these and other metabolic diseases.

Researchers have shown that expression of specific miRNAs attenuated glomerular hypertrophy, one of the earliest pathological abnormalities in diabetic nephropathy, indicating it may represent a novel therapeutic target.

Others found that a specific miRNA is dramatically upregulated during osteoclastic differentiation of circulating peripheral blood mononuclear cells and its inhibition attenuated osteoclastogenesis.

Read more about how LC Sciences is helping clinicians and researchers to:

LC Sciences offers a portfolio of services applicable to metabolic diseases and metabolomic research.
Contact us to find out more.

16S rRNA Gene Sequencing
16S rRNA gene sequencing is commonly used for identification, classification and quantitation of microbes within complex biological mixture such as environmental samples (ex marine water) and gut samples…

VariantPro Mitochondrial Panel
Designed for 100% amplicon coverage (16,569 bp) of the mitochondrial genome, the Mitochondrion Panel offers cost-effective, minimal hands-on, ultra-high resolution…

RNA Sequencing Services

microRNA Profiling Services

microRNAs are small noncoding RNA molecules that function broadly as negative regulators of gene expression to control a wide range of cellular processes. A genome-wide microRNA (miRNA) expression profiling service…